May 21 () - Sichuan Kelun-Biotech Biopharmaceutical said on Thursday its experimental treatment combined with partner Merck's ...
A type of targeted chemotherapy developed by China-based Kelun-Biotech and licensed to Merck cut the risk of tumor ...
May 18 (Reuters) - Merck said on Monday its experimental drug helped certain patients with uterine cancer live longer and ...
Biotech’s antibody-drug conjugate significantly improved progression-free and overall survival in a pivotal endometrial ...
The endometrial cancer trial is the first of 17 late-stage studies Merck is running for a therapy that’s important to its ...
May 18 (Reuters) - Merck said on Monday its experimental drug met the main goals of a late-stage trial in patients with a ...
Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE ®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart ...
Eli Lilly LLY and MerckMRK are leading global pharmaceutical companies with blockbuster drug portfolios and strong pipelines.
FRANKFURT (Reuters) -Germany's Merck KGaA on Thursday agreed to use Boston-based Valo Health's drug research services in a collaboration focused on Parkinson's and related diseases that is potentially ...
Merck KGaA, Darmstadt, Germany, Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results